Abstract
This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.
| Original language | English |
|---|---|
| Article number | hyr194 |
| Pages (from-to) | 226-236 |
| Number of pages | 11 |
| Journal | Japanese Journal of Clinical Oncology |
| Volume | 42 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Mar 2012 |
| Externally published | Yes |
Fingerprint
Keywords
- Androgen deprivation therapy
- J-CAPRA
- Overall survival
- Prostate cancer
- Risk stratification
ASJC Scopus subject areas
- Oncology
- Cancer Research
- Radiology Nuclear Medicine and imaging
Cite this
Fifth joint meeting of J-CaP and CaPSURE : Advancing the global understanding of prostate cancer and its management. / Akaza, Hideyuki; Carroll, Peter; Cooperberg, Matthew R.; Hinotsu, Shiro.
In: Japanese Journal of Clinical Oncology, Vol. 42, No. 3, hyr194, 03.2012, p. 226-236.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Fifth joint meeting of J-CaP and CaPSURE
T2 - Advancing the global understanding of prostate cancer and its management
AU - Akaza, Hideyuki
AU - Carroll, Peter
AU - Cooperberg, Matthew R.
AU - Hinotsu, Shiro
PY - 2012/3
Y1 - 2012/3
N2 - This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.
AB - This report summarizes the presentations and discussions that took place at the Fifth Joint Meeting of J-CaP and CaPSURE held in Tokyo, Japan, in July 2011. The J-CaP and CaPSURE Joint Initiative was established in 2007 with the objective of analyzing, reviewing, comparing and contrasting data on prostate cancer patients from Japan and the USA within the two important large-scale, longitudinal, observational databases-J-CaP and CaPSURE. Since its inception, the initiative has reviewed a wide range of topics and generated valuable data on the patterns of prostate cancer treatment and patient outcomes in the two geographical regions. The objectives of this 5th Joint Meeting were to provide an update on the current status of the J-CaP and CaPSURE databases, and also to discuss perspectives from a range of other Asian countries-Japan, China, Indonesia and Korea-on the use of androgen deprivation therapy for prostate cancer. The collaborators recognize that large databases, such as J-CaP and CaPSURE, provide valuable 'real-world' information, to complement data from clinical trials, which can help to advance the clinical management of prostate cancer patients worldwide. It is anticipated that in the near future, the Joint Initiative will expand globally to include patient registries from other countries so that best practice can be shared and regional differences in patients, treatments and outcomes can be explored.
KW - Androgen deprivation therapy
KW - J-CAPRA
KW - Overall survival
KW - Prostate cancer
KW - Risk stratification
UR - http://www.scopus.com/inward/record.url?scp=84857946027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84857946027&partnerID=8YFLogxK
U2 - 10.1093/jjco/hyr194
DO - 10.1093/jjco/hyr194
M3 - Article
C2 - 22217576
AN - SCOPUS:84857946027
VL - 42
SP - 226
EP - 236
JO - Japanese Journal of Clinical Oncology
JF - Japanese Journal of Clinical Oncology
SN - 0368-2811
IS - 3
M1 - hyr194
ER -